174 related articles for article (PubMed ID: 33893920)
1. Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case-Control Study.
Unal E; Aslan EI; Ozturk T; Kurnaz Gomleksiz O; Kucukhuseyin O; Tuzuner MB; Seyhan MF; Ozturk O; Yilmaz Aydogan H
Biochem Genet; 2021 Dec; 59(6):1413-1426. PubMed ID: 33893920
[TBL] [Abstract][Full Text] [Related]
2. PPARγ Pro12Ala and C161T polymorphisms in patients with acne vulgaris: Contribution to lipid and lipoprotein profile.
Saeidi S; Chamaie-Nejad F; Ebrahimi A; Najafi F; Rahimi Z; Vaisi-Raygani A; Shakiba E; Rahimi Z
Adv Med Sci; 2018 Mar; 63(1):147-151. PubMed ID: 29120856
[TBL] [Abstract][Full Text] [Related]
3. Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with cardiovascular risk factors in maintenance hemodialysis patients.
Liu F; Mei X; Zhang Y; Qi H; Wang J; Wang Y; Jiang W; Zhang X; Yan H; Zhuang S
Mol Biol Rep; 2014 Nov; 41(11):7555-65. PubMed ID: 25096510
[TBL] [Abstract][Full Text] [Related]
4. The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility.
Kurnaz-Gomleksiz O; Torun BC; Isbir T; Bulut T; Sokucu N; Yilmaz-Aydogan H; Canbay E
In Vivo; 2022; 36(4):1911-1915. PubMed ID: 35738614
[TBL] [Abstract][Full Text] [Related]
5. Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome.
Dongxia L; Qi H; Lisong L; Jincheng G
Circ J; 2008 Apr; 72(4):551-7. PubMed ID: 18362424
[TBL] [Abstract][Full Text] [Related]
6. The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles.
Rahimi Z; Chamaie-Nejad F; Saeidi S; Rahimi Z; Ebrahimi A; Shakiba E; Vaisi-Raygani A
Int J Fertil Steril; 2018 Jul; 12(2):147-151. PubMed ID: 29707932
[TBL] [Abstract][Full Text] [Related]
7. Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population.
Jiang J; Gajalakshmi V; Wang J; Kuriki K; Suzuki S; Nakamura S; Akasaka S; Ishikawa H; Tokudome S
Cancer Sci; 2005 Aug; 96(8):507-12. PubMed ID: 16108832
[TBL] [Abstract][Full Text] [Related]
8. Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India.
Bhatt SP; Nigam P; Misra A; Guleria R; Luthra K; Pandey RM; Pasha MA
Gene; 2013 Jan; 512(1):143-7. PubMed ID: 23031808
[TBL] [Abstract][Full Text] [Related]
9. Joint effect of peroxisome proliferator-activated receptor γ genetic polymorphisms and estrogen-related risk factors on breast cancer risk: results from a case-control study in Taiwan.
Wu MH; Chu CH; Chou YC; Chou WY; Yang T; Hsu GC; Yu CP; Yu JC; Sun CA
Breast Cancer Res Treat; 2011 Jun; 127(3):777-84. PubMed ID: 21140205
[TBL] [Abstract][Full Text] [Related]
10. Common PPARγ variants C161T and Pro12Ala are not associated with inflammatory bowel disease in an Australian cohort.
Hume GE; Fowler EV; Griffiths LR; Doecke JD; Radford-Smith GL
J Gastrointestin Liver Dis; 2012 Dec; 21(4):349-55. PubMed ID: 23256116
[TBL] [Abstract][Full Text] [Related]
11. PPARgamma polymorphisms and cancer risk: a meta-analysis involving 32,138 subjects.
Xu W; Li Y; Wang X; Chen B; Liu S; Wang Y; Zhao W; Wu J
Oncol Rep; 2010 Aug; 24(2):579-85. PubMed ID: 20596649
[TBL] [Abstract][Full Text] [Related]
12. The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma gene with serum osteoprotegerin levels in healthy Korean women.
Rhee EJ; Oh KW; Yun EJ; Jung CH; Park CY; Lee WY; Oh ES; Baek KH; Kang MI; Park SW; Kim SW
Exp Mol Med; 2007 Dec; 39(6):696-704. PubMed ID: 18160840
[TBL] [Abstract][Full Text] [Related]
13. Associations of receptor for advanced glycation end products -374 T/A and Gly82 Ser and peroxisome proliferator-activated receptor gamma Pro12Ala polymorphisms in Turkish coronary artery disease patients.
Aydoğan HY; Küçükhüseyin O; Tekeli A; Isbir T
Genet Test Mol Biomarkers; 2012 Feb; 16(2):134-7. PubMed ID: 21861709
[TBL] [Abstract][Full Text] [Related]
14. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease.
Shrestha UK; Karimi O; Crusius JB; Zhou F; Wang Z; Chen Z; van Bodegraven AA; Xiao J; Morré SA; Wang H; Li J; Xia B
Inflamm Bowel Dis; 2010 Feb; 16(2):312-9. PubMed ID: 19714744
[TBL] [Abstract][Full Text] [Related]
15. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
[TBL] [Abstract][Full Text] [Related]
16. Association between Peroxisome Proliferator-activated Receptor Gamma Gene Polymorphisms and Atherosclerotic Diseases: A Meta-analysis of Case-control Studies.
Wang P; Wang Q; Yin Y; Yang Z; Li W; Liang D; Zhou P
J Atheroscler Thromb; 2015; 22(9):912-25. PubMed ID: 25832497
[TBL] [Abstract][Full Text] [Related]
17. Associations between C1431T and Pro12Ala variants of PPARγ gene and their haplotypes with susceptibility to metabolic syndrome in an Iranian population.
Rooki H; Haerian MS; Azimzadeh P; Mirhafez R; Ebrahimi M; Ferns G; Ghayour-Mobarhan M; Zali MR
Mol Biol Rep; 2014 May; 41(5):3127-33. PubMed ID: 24464185
[TBL] [Abstract][Full Text] [Related]
18. Meat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARgamma gene and colorectal cancer risk in Japanese.
Kuriki K; Hirose K; Matsuo K; Wakai K; Ito H; Kanemitsu Y; Hirai T; Kato T; Hamajima N; Takezaki T; Suzuki T; Saito T; Tanaka R; Tajima K
Cancer Sci; 2006 Nov; 97(11):1226-35. PubMed ID: 16965392
[TBL] [Abstract][Full Text] [Related]
19. Interaction of genetic risk factors confers increased risk for metabolic syndrome: the role of peroxisome proliferator-activated receptor γ.
Božina T; Sertić J; Lovrić J; Jelaković B; Šimić I; Reiner Ž
Genet Test Mol Biomarkers; 2014 Jan; 18(1):32-40. PubMed ID: 24200052
[TBL] [Abstract][Full Text] [Related]
20. Lack of effects of peroxisome proliferator-activated receptor gamma genetic polymorphisms on breast cancer risk: a case-control study and pooled analysis.
Park B; Shin A; Kim KZ; Lee YS; Hwang JA; Kim Y; Sung J; Yoo KY; Lee ES
Asian Pac J Cancer Prev; 2014; 15(21):9093-9. PubMed ID: 25422184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
